Tau Antibodies May Best Treat Alzheimer’s by Avoiding an Inflammatory Trigger

Tau Antibodies May Best Treat Alzheimer’s by Avoiding an Inflammatory Trigger
Researchers at Genentech discovered that antibodies against tau — a protein creating toxic tangles inside nerve cells of people with Alzheimer’s disease — protect from tau toxicity only when antibodies don’t engage inflammation-triggering microglial cells to get rid of the protein. The findings, published in the journal Cell Reports under the title “Antibody-Mediated Targeting of

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *